Financing channel feed

UniQure reach­es mile­stone, Idor­si­a's bridge fi­nanc­ing ex­tends run­way, and Phar­varis scores $70M place­ment

Last year

Fra­zier and Ala­mar Bio­sciences cre­ate im­mune and can­cer biotech At­tovia with $60M in fund­ing

Last year
Startups

Mol­e­c­u­lar Tem­plates cuts more staff just months af­ter let­ting go half of work­force

Last year

All aboard the pub­lic fi­nanc­ing train! Zen­tal­is, Ed­i­tas, Ve­rastem, Prax­is and Clene, among oth­ers, raise funds

Last year

Ex­clu­sive: mR­NA CD­MO Ver­nal Bio­sciences se­cures $20M to con­tin­ue its build­out

Last year
Manufacturing

Tis­sue re­gen­er­a­tion biotech rais­es $26M Se­ries A to push to­ward clin­i­cal tri­als

Last year

Syn­cona takes write-down on Swan­Bio as biotech halves work­force to fo­cus on one gene ther­a­py

Last year
Startups
Cell/Gene Tx

Small pri­vate biotechs raise mon­ey in most­ly ear­ly-stage fi­nanc­ing

Last year

Turn­stone Bi­o­log­ics turns to pub­lic in­vestors to fund TIL ther­a­pies in IPO fil­ing

Last year
Cell/Gene Tx

With promis­ing PhII blood dis­or­der da­ta in hand, Disc Med­i­cine seeks $100M in pub­lic of­fer­ing

Last year

Catal­ent’s Q3 rev­enue fell 19% in de­layed re­veal of fi­nan­cial re­sults

Last year
Manufacturing

Ec­co­gene nabs $25M Se­ries B for GLP-1 and a NASH drug can­di­date, as com­peti­tors lap the Chi­na biotech

Last year
Startups
China

Ex-Night­star, Gy­ro­scope and AGTC teams try again for next reti­nal gene ther­a­py with $120M for Bea­con Ther­a­peu­tics

Last year
Startups
Cell/Gene Tx

Oslo biotech finds an­oth­er merg­er part­ner af­ter share­hold­ers re­ject­ed No­vem­ber of­fer

Last year
Deals

Lyn­dra Ther­a­peu­tics eyes $180M Se­ries D for po­ten­tial 2026 launch of once-week­ly schiz­o­phre­nia med

Last year
Startups
R&D

Up­stream Bio match­es first fund­ing round with an­oth­er $200M to get asth­ma drug to PhI­II

Last year
Startups

LNP biotech looks to go be­yond the liv­er, rais­ing $25M in seed mon­ey to move for­ward

Last year

Bit­ter­root Bio nabs $145M Se­ries A with a plan to tack­le chal­leng­ing can­cer tar­get for heart med­i­cines

Last year
Startups

Day One goes to the mar­ket for $150M as biotech kicks off NDA re­quest for pe­di­atric brain can­cer drug

Last year
R&D

Co­gent Bio­sciences fol­lows AS­CO da­ta drop for KIT in­hibitor with up­sized $150M pub­lic stock of­fer­ing

Last year

Ace­po­di­a's off-the-shelf cell ther­a­pies get an­oth­er $100M for on­col­o­gy tri­als

Last year
Startups
Cell/Gene Tx

Bain leads $150M round to push blind­ness biotech's rare dis­ease drug to­ward FDA

Last year

Cana­di­an CD­MO se­cures more fund­ing to get its man­u­fac­tur­ing site up and run­ning

3 years ago
Manufacturing

Dol­lars flow with three new pub­lic of­fer­ings, two pri­vate place­ments

3 years ago
First page Previous page 32333435363738 Next page Last page
A service from the Financial Times